Mallinckrodt, Premier broaden agreement

Article

Mallinckrodt has expanded its agreement with group purchasing organization Premier, adding new products and extending their existing contract by two years. New Mallinckrodt technologies and products added to the partnership include Nellcor pulse

Mallinckrodt has expanded its agreement with group purchasing organization Premier, adding new products and extending their existing contract by two years. New Mallinckrodt technologies and products added to the partnership include Nellcor pulse oximeters and sensors, Liebel-Flarsheim power injector disposables, and the Optison ultrasound contrast agent (developed by San Diego-based Molecular Biosystems).

The earlier agreement between Premier and Mallinckrodt covered other Mallinckrodt contrast imaging agents, radiopharmaceuticals and related products, endotracheal tubes, tracheostomy tubes, and temperature monitoring systems. All of those items will remain under the new expanded agreement, which will conclude at the end of 2006, according to St. Louis-based Mallinckrodt.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.